Skip navigation
About
People
Research
Services
Education
Menu
News
Events
Blog
Give
Publications
Software
Contact
Search
Search
Search
Search
About
People
Research
Services
Education
News
Events
Blog
Give
Publications
Software
Contact
A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease